Making proteins for research or therapies often starts with cell-line development. In many applications, genetic engineering is used to optimize a cell line for producing high levels of the intended protein. Researchers and companies often start with Chinese hamster ovary (CHO) cells or human embryonic kidney (HEK) cells, but many other options can be considered. In addition, many emerging tools, especially AI-based ones, can improve…